KFDA approves amlodipine adipate

CJ Corporation said its new amlodipine adipate (brandname: Amlosta tablet) has been approved for marketing by the Korea Food and Drug Administration, based on the results of local Phase III clinical trials involving 211 subjects in 15 general hospitals including Seoul National University.

The company said studies have demonstrated that amlodipine adipate is comparable to other amlodipine sal...